Nadeem Riaz

🥳🎆 Kicking of 2026 with our work showing intra-tumoral bacteria 🦠 affect outcomes of Radiotherapy + anti-PD-L1 now out in @NatureCancer with sister paper by @nataliesilvermd! Even when trials "fail" – we can learn from them! nature.com/articles/s4301…. -- w/ @GeneCollector, @imrtlee, @TylerAlban1, @DrHaddadRobert, the Pfizer team and more! (1/N)

7y in the making!!! As I always spoke about this, the field of #NasopharyngealCarcinoma leads the way in driving individualised treatment in #HeadNeckCancer When we published our initial idea of stratifying patients by their early treatment response using #EBVDNA back then in 2018, we decided to test our idea formally with a trial, and kudos to a very talented #biostats and willing collaborators, we came up with EP-STAR Very glad to see it finally published today in @Nature 🍸 nature.com/articles/s4158…

🚨Happening now #MHNCS26 @ASTRO_org - going viral - virus mediated head/neck cancer. @imrtlee @xrtGenomics

AI is cool and all... but a new paper in @ScienceMagazine kind of figured out the origin of life? The paper reports the discovery of a simple 45-nucleotide RNA molecule that can perfectly copy itself.

Congragulations Luis (@ldiaz1971) on being awarded the 2026 Gustave Roussy Prize!! A truly amazing scientist, oncologist, mentor, and leader who has the rare gift for building the multidisciplinary teams needed to move cutting-edge science into the clinic to benefit patients. youtube.com/watch?v=pvyUJO…

Our review article is finally out. A labor of love and a year worth of work. The best part is I got to do it with my mentee🩷. Many thanks to @gabe_brewer for the invitation, guidance, and insight and for the dedicated reviewers for great feedback. nature.com/articles/s4156…

This is a remarkable document — although not meant for scientists — maybe beneficial for those who communicate science to the public to read

📢Come join us! From patient perspective to practice-changing data: HPV− & viral (HPV/EBV) HNSCC, neoadjuvant & periop IO, ctDNA-guided de-/escalation, KEYNOTE-689, AI & supportive tech, thyroid, salivary tumors & survivorship/QoL! @KaramLab @xrtGenomics @imrtlee @DavidSherMD

Early-stage research in the U.S. is often mired in red tape, while other countries sprint ahead. It’s time to move to centralized IRBs and streamline the hospital contracting process.

@iskander How many people have deeply learned assembly? pseudo code will really be all you need —maybe not even …

I'm late to all trends. So...a few years after people smarter than me, I'm thinking about (1) will software stacks ossify into 2020s tech or become incomprehensibly alien (2) is it still possible to deeply learn programming

@CedricPetersRT @NatureCancer @nataliesilvermd @GeneCollector Thx Cedric! We weren’t able to look at antibiotics in this study — but this is an area we and others are definitely interested in! There are obvious interactions with gut microbiome — so it’s not straight forward

@xrtGenomics @NatureCancer @nataliesilvermd @GeneCollector Congratulations on this amazing work. Did you find any effect of antibiotics or alcohol on treatment outcome? They could have a significant impact on tumor microbiome.

🥳🎆 Kicking of 2026 with our work showing intra-tumoral bacteria 🦠 affect outcomes of Radiotherapy + anti-PD-L1 now out in @NatureCancer with sister paper by @nataliesilvermd! Even when trials "fail" – we can learn from them! nature.com/articles/s4301…. -- w/ @GeneCollector, @imrtlee, @TylerAlban1, @DrHaddadRobert, the Pfizer team and more! (1/N)

@ScottBratman @NatureCancer @nataliesilvermd @GeneCollector Thanks Scott!

@xrtGenomics @NatureCancer @nataliesilvermd @GeneCollector Congrats on the impactful work!

@KaramLab @NatureCancer @nataliesilvermd @GeneCollector Thanks Sana! We hope the data is useful for others!

@xrtGenomics @NatureCancer @nataliesilvermd @GeneCollector Awesome work, you guys! This is an incredible amount of work, effort, and resources. Thank you!!

@SeanPitroda @NatureCancer @nataliesilvermd @GeneCollector Thanks Sean!

@xrtGenomics @NatureCancer @nataliesilvermd @GeneCollector Congrats!

@jdschoenfeld1 @NatureCancer @nataliesilvermd @GeneCollector Thanks Jonathan! I hope we can see more correlative science in even negative H&N studies in the future. When we are surprised by a trial result, we need to learn from it!

@xrtGenomics @NatureCancer @nataliesilvermd @GeneCollector Huge congratulations to the team 🎉. So much to dig into and explore in future studies. A great example of how detailed correlative science can move the field forward even when trials don’t meet their primary endpoints.

@rweichselbaum @NatureCancer @nataliesilvermd @GeneCollector thx Ralph!

@xrtGenomics @NatureCancer @nataliesilvermd @GeneCollector Congratulations Nadeem fantastic work!!

A focus as we started our lab @ClevelandClinic was to understand cancer-type dependent drivers of ICI response. In our paper published in @NatureCancer with @nataliesilvermd, we show how bacteria can drive ICI resistance in head and neck cancers. (1/N) nature.com/articles/s4301…